We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FairJourney Biologics Enters Next-Generation Antibody Discovery Collaboration With Argenx

Product News   Apr 13, 2021

 
FairJourney Biologics Enters Next-Generation Antibody Discovery Collaboration With Argenx
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Lonza Announces Results of the 2021 Annual General Meeting

Product News

Lonza Group Ltd has hosted its Annual General Meeting, led by the Chairman of the Board of Directors, Albert M. Baehny.

READ MORE

DefiniGEN Appoints Chairman to Further Expand Preclinical Drug Development Capabilities

Product News

DefiniGEN has announced the appointment of Dr Ben Cons as Chairman of the Board. A respected entrepreneur and pharmaceutical and healthcare leader, he has a proven track record and brings more than 30 years’ experience in pharmaceutical R&D & commercialization across the biotech, pharmaceutical and financing sectors.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE